Geneos Wealth Management’s iShares MSCI Sweden ETF EWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.55K Hold
51
– – ﹤0.01% 2296
2026
Q1
$2.48K Hold
51
– – ﹤0.01% 2280
2025
Q4
$2.51K Hold
51
– – ﹤0.01% 2283
2025
Q3
$2.41K Sell
51
-33,721
-100% -$1.56M ﹤0.01% 2291
2025
Q2
$1.54M Buy
33,772
+194
+0.6% +$8.51K 0.04% 422
2025
Q1
$1.41M Buy
33,578
+33,527
+65,739% +$1.41M 0.05% 376
2024
Q4
$1.9K Hold
51
– – ﹤0.01% 2609
2024
Q3
$2.21K Hold
51
– – ﹤0.01% 2277
2024
Q2
$2.05K Sell
51
-1,023
-95% -$41.3K ﹤0.01% 1883
2024
Q1
$42.9K Buy
+1,074
New +$41.5K ﹤0.01% 1123
2018
Q4
– Sell
-210
Closed -$6K – 2409
2018
Q3
$6K Hold
210
– – ﹤0.01% 2008
2018
Q2
$6K Hold
210
– – ﹤0.01% 1866
2018
Q1
$7K Hold
210
– – ﹤0.01% 1756
2017
Q4
$7K Buy
210
+182
+650% +$6.36K ﹤0.01% 1730
2017
Q3
$1K Buy
+28
New +$969 ﹤0.01% 2036

Other funds holding EWD

Geneos Wealth Management's EWD Position: Q2 2026 in Review

Geneos Wealth Management held its iShares MSCI Sweden ETF (EWD) position steady in Q2 2026 at 51 shares worth $2.55K. The position accounts for ﹤0.01% of the portfolio, ranked #2296.

Geneos Wealth Management first reported a position in EWD in Q3 2017 and has held it in 15 quarters since. The position peaked at $1.54M in Q2 2025. 91 funds tracked by Wall St. Rank hold EWD as of Q2 2026.

  • Geneos Wealth Management held 51 shares of iShares MSCI Sweden ETF worth $2.55K as of Q2 2026.
  • Geneos Wealth Management left its iShares MSCI Sweden ETF share count unchanged in Q2 2026.
  • iShares MSCI Sweden ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #2296 holding.
  • Geneos Wealth Management first reported a position in iShares MSCI Sweden ETF in Q3 2017 and has held it in 15 quarters since.
  • Geneos Wealth Management's iShares MSCI Sweden ETF position peaked at $1.54M in Q2 2025.
  • 91 funds tracked by Wall St. Rank held iShares MSCI Sweden ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.